Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBruising at the Mounjaro injection site is common and, in most cases, harmless. It usually appears as a small purple or red mark in the hours after your weekly injection and fades within a few days. Tirzepatide bruising at the injection site tends to happen when a tiny blood vessel is nicked during the injection — not a sign that anything has gone wrong with the medicine or the dose. That said, there are practical steps that reliably reduce how often it happens, and a few signs that do deserve a call to your clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The skin and the layer just beneath it are threaded with tiny capillaries. When a needle passes through, it occasionally clips one of these vessels. The result is a small bleed that pools under the skin, the classic purplish mark that might appear an hour or two after your weekly dose. It's the needle and the technique, not tirzepatide itself, doing the work here.
A few things make it more likely. Injecting into the same spot repeatedly gives tissue less time to recover between doses. Cold skin is less forgiving than warm skin. And if you press the pen down hard or pull it away too quickly, you're more likely to catch a vessel on the way in or out. Blood-thinning medicines (aspirin, warfarin, apixaban, ibuprofen taken regularly) increase the chance of bruising for anyone injecting subcutaneously, regardless of which medicine is in the pen.
The NHS tirzepatide patient information page notes injection-site reactions, including bruising, as a recognised side effect. They're listed under common rather than serious reactions, which is reassuring framing from the clinical record. If you want to understand why bruising from a Mounjaro injection happens and how to manage it, we cover the causes and remedies in detail. You can read more about the full injection experience on our guide to Mounjaro injections.
It does, noticeably. The three licensed sites for Mounjaro are the abdomen (avoiding the two inches immediately around the navel), the front or outer thigh, and the upper arm. Most people find the abdomen gives the most consistent results, partly because there's generally more subcutaneous fat and fewer surface vessels running close to the skin.
The upper arm can be trickier to reach at the right angle when you're injecting yourself, which increases the chance of an imperfect entry. The thigh is a solid alternative for most people, though some find it slightly more sensitive. The point that matters most is rotation: moving at least 2–3 cm from your last injection spot each week prevents the cumulative tissue trauma that makes bruising worse over time.
Our page on choosing the right injection site covers the positioning in more detail if you're finding one area more problematic than others.
A few technique changes make a real, consistent difference. First, let the pen come to room temperature before you inject, a cold pen from the fridge causes more local discomfort and can contribute to bruising, so taking it out around 30 minutes beforehand helps. Many people keep their pen in the fridge door and just pull it out while the kettle boils.
Before you begin, clean the skin with an alcohol swab and let it dry fully, injecting through wet skin increases sting and can affect how cleanly the needle enters. Hold the pen at a 90-degree angle and apply gentle, steady pressure until you hear the click, then hold it in place for the full recommended count before withdrawing. Rushing the withdrawal is one of the most common reasons people get unnecessary bruising.
After the needle is out, apply gentle pressure with a clean finger or cotton ball for about ten seconds. Do not rub, rubbing spreads the small bleed. If bruising is a persistent issue for you, our guide specifically on reducing Mounjaro injection bruising goes through each of these steps in more depth. For anyone refreshing their supplies, pre-saturated alcohol swabs are a convenient way to keep site preparation consistent.
On the topic of what Mounjaro costs and whether technique support is included in what you pay, it's worth knowing that Eli Lilly's UK price increase from September 2025 changed the market significantly, understanding why prices vary between providers matters when you're weighing up your options.
Most bruising from a Mounjaro injection resolves without any intervention in three to five days. The bruise may go through the usual colour progression (purple to green to yellow) before fading entirely. That's normal.
Contact your clinical team if: the bruise is unusually large (bigger than a 50p coin), spreading rather than fading after 48 hours, warm to the touch, or accompanied by swelling, hardness or pain beyond mild tenderness. These could indicate a haematoma or, less commonly, an early infection at the site, both of which need a prescriber's eyes on them. Pain that radiates away from the injection site, or persistent redness tracking outward, warrants prompt attention.
You can reach the team through our support page, where aftercare is available seven days a week. For a fuller picture of injection-site care from the first dose onwards, our safety guide for Mounjaro covers what to watch for at each stage of treatment. If you're still exploring whether Mounjaro is the right route for you, our weight-loss treatment overview puts it in context alongside other options.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.